[ACRX] QoQ Quarter Result on 30-Sep-2021 [#Q3]

Stock
[ACRX] AcelRx Pharmaceuticals, Inc.
Announcement Date
15-Nov-2021
Financial Year
2021
Quarter
30-Sep-2021 [#Q3]
Profit Trend
QoQ- 14.98%
YoY- 6.22%
Quarter Report
ACRX's Result
ACRX's Financial Summary
View:
Show?
Quarter Result
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
Revenue 570 442 2 1,862 443 511 738 -15.85%
PBT 70,666 -8,674 -7,917 -8,375 -9,846 -8,956 -8,918 -
Tax 3 -321 467 796 5 858 698 -97.38%
NP 70,663 -8,353 -7,917 -8,375 -9,851 -8,956 -8,918 -
Tax Rate -0.00% - - - - - - -
Total Cost -70,093 8,795 7,919 10,237 10,294 9,467 9,656 -
Ratio Analysis
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
NP Margin 12,397.02 -1,889.82 -395,850.00 -449.79 -2,223.70 -1,752.64 -1,208.40 -
Per Share
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
EPS 9.60 -1.15 -1.24 -1.40 -1.65 -1.58 -1.93 -
EPS Diluted 9.60 -1.15 -1.24 -1.40 -1.65 -1.58 -1.93 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.